← FDA Drug Approvals (Drugs@FDA)

FLUXID

NDA · New Drug Application · Sponsor: UCB INC · Approved 2004-09-24

Drug application

FDA Application #

NDA021712

Application type

New Drug Application

Brand name

FLUXID

Generic name

Famotidine

Active ingredients

FAMOTIDINE

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Discontinued

Sponsor

UCB INC

First approval

2004-09-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown